Skip to main content
SpringerLink
Log in

Physiological Effects of Androgens in Women

  • Chapter
Androgen Excess Disorders in Women

Part of the book series: Contemporary Endocrinology ((COE))

Abstract

Androgens are important sex steroid hormones for women as well as men. Previously, the focus of androgen research in women was almost exclusively on issues of excess. Only recently have we become aware that androgens play an important role in many aspects of the health and well-being of women. From sexual orientation to brain development to bone health, androgens are closely intertwined with estrogens, and only by understanding the former can we have a full understanding of women’ health and their medical care issues. This chapter focuses on the normal physiology of androgens in women—what we know and what we have yet to learn.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 269.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Burger HG. Androgen production in women. Fertil Steril 2002;77(Suppl 4):S3–S5.

    Article  PubMed  Google Scholar 

  2. Cohen-Bendahan CC, vande Beek C, Berenbaum SA. Prenatal sex hormone effects on child and adult sex-typed behavior: methods and findings. Neurosci Biobehav Rev 2005;29(2):353–384.

    Article  PubMed  CAS  Google Scholar 

  3. Rhen T, Cidlowski JA. Steroid hormone action. In: Strauss JIII, Barbieri R, eds. Yen and Jaffe’ Reproductive Endocrinology, 5th ed. Philadelphia: Elsevier Saunders, 2004:155–174.

    Google Scholar 

  4. Parker LN, Odell WD. Evidence for existence of cortical androgen-stimulating hormone. Am J Physiol 1979;236(6):E616–620.

    PubMed  CAS  Google Scholar 

  5. Rivera-Woll LM, Papalia M, Davis SR, Burger HG. Androgen insufficiency in women: diagnostic and therapeutic implications. Hum Reprod Update 2004;10(5):421–432.

    Article  PubMed  CAS  Google Scholar 

  6. Cameron DR, Braunstein GD. Androgen replacement therapy in women. Fertil Steril 2004;82(2):273–289.

    Article  PubMed  CAS  Google Scholar 

  7. Labrie F, Luu-The V, Labrie C, et al. Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone. Endocr Rev 2003;24(2):152–182.

    Article  PubMed  CAS  Google Scholar 

  8. Tchernitchin A. The role of eosinophil receptors in the non-genomic response to oestrogens in the uterus. J Steroid Biochem 1979;11(1B):417–424.

    Article  PubMed  CAS  Google Scholar 

  9. Revelli A, Massobrio M, Tesarik J. Nongenomic actions of steroid hormones in reproductive tissues. Endocr Rev 1998;19(1):3–17.

    Article  PubMed  CAS  Google Scholar 

  10. Lösel RM, Falkenstein E, Feuring M, et al. Nongenomic steroid action: controversies, questions, and answers. Physiol Rev 2003;83(3):965–1016.

    Google Scholar 

  11. Heinlein CA, Chang C. The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions. Mol Endocrinol 2002;16(10):2181–2187.

    Article  PubMed  CAS  Google Scholar 

  12. Willnow TE, Nykjaer A, Herz J. Lipoprotein receptors: new roles for ancient proteins. Nat Cell Biol 1999;1(6):E157–E162.

    Article  PubMed  CAS  Google Scholar 

  13. Nykjaer A, Willnow TE. The low-density lipoprotein receptor gene family: a cellular Swiss army knife? Trends Cell Biol 2002;12(6):273–280.

    Article  PubMed  CAS  Google Scholar 

  14. Lee MM. Molecular genetic control of sex differentiation. In: Pescovitz OH, Eugster EA, eds. Pediatric Endocrinology: Mechanisms, Manifestations, and Management. Philadelphia: Lippincott Williams & Wilkins;2004:231–242.

    Google Scholar 

  15. Sultan C, Lumbroso S, Paris F, et al. Disorders of androgen action. Semin Reprod Med 2002;20(3):217–228.

    Article  PubMed  CAS  Google Scholar 

  16. Gottlieb B, Pinsky L, Beitel LK, Trifiro M. Androgen insensitivity. Am J Med Genet 1999;89(4):210–217.

    Article  PubMed  CAS  Google Scholar 

  17. New MI. Clinical and endocrinological aspects of 21-hydroxylase deficiency. Ann NY Acad Sci 1985;458:1–27.

    Article  PubMed  CAS  Google Scholar 

  18. Kelly SJ, Ostrowski NL, Wilson MA. Gender differences in brain and behavior: hormonal and neural bases. Pharmacol Biochem Behav 1999;64(4):655–664.

    Article  PubMed  CAS  Google Scholar 

  19. Hines M, Brook C, Conway GS. Androgen and psychosexual development: core gender identity, sexual orientation and recalled childhood gender role behavior in women and men with congenital adrenal hyperplasia (CAH). J Sex Res 2004;41(1):75–81.

    Article  PubMed  Google Scholar 

  20. Berenbaum SA, Bailey JM. Effects on gender identity of prenatal androgens and genital appearance: evidence from girls with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2003;88(3):1102–1106.

    Article  PubMed  CAS  Google Scholar 

  21. Hines M, Ahmed SF, Hughes IA. Psychological outcomes and gender-related development in complete androgen insensitivity syndrome. Arch Sex Behav 2003;32(2):93–101.

    Article  PubMed  Google Scholar 

  22. Wisniewski AB, Migeon CJ, Meyer-Bahlburg HF, et al. Complete androgen insensitivity syndrome: long-term medical, surgical, and psychosexual outcome. J Clin Endocrinol Metab 2000;85(8):2664–2669.

    Article  PubMed  CAS  Google Scholar 

  23. Quigley CA. Editorial: The postnatal gonadotropin and sex steroid surge-insights from the androgen insensitivity syndrome. J Clin Endocrinol Metab 2002;87(1):24–28.

    Article  PubMed  CAS  Google Scholar 

  24. Reiter EO, Grumbach MM, Kaplan SL, Conte FA. The response of pituitary gonadotropes to synthetic LRF in children with glucocorticoid-treated congenital adrenal hyperplasia: lack of effect of intrauterine and neonatal androgen excess. J Clin Endocrinol Metab 1975;40(2):318–325.

    PubMed  CAS  Google Scholar 

  25. Vanderschueren D, Vandenput L, Boonen S, Lindberg MK, Bouillon R, Ohlsson C. Androgens and bone. Endocr Rev 2004;25(3):389–425.

    Article  PubMed  CAS  Google Scholar 

  26. Frank GR. Role of estrogen and androgen in pubertal skeletal physiology. Med Pediatr Oncol 2003;41(3):217–221.

    Article  PubMed  Google Scholar 

  27. Conte FA, Grumbach MM, Ito Y, Fisher CR, Simpson ER. A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom). J Clin Endocrinol Metab 1994;78(6):1287–1292.

    Article  PubMed  CAS  Google Scholar 

  28. Auchus RJ, Rainey WE. Adrenarche-physiology, biochemistry and human disease. Clin Endocrinol 2004;60(3):288–296.

    Article  CAS  Google Scholar 

  29. Hiort O. Androgens and puberty. Best Pract Res Clin Endocrinol Metab 2002;16(1):31–41.

    Article  PubMed  CAS  Google Scholar 

  30. Zumoff B, Strain GW, Miller LK, Rosner W. Twenty-four-hour mean plasma testosterone concentration declines with age in normal premenopausal women. J Clin Endocrinol Metab 1995;80(4):1429–1430.

    Article  PubMed  CAS  Google Scholar 

  31. Labrie F, Belanger A, Cusan L, Gomez JL, Candas B. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. J Clin Endocrinol Metab 1997;82(8):2396–2402.

    Article  PubMed  CAS  Google Scholar 

  32. Lasley BL, Santoro N, Randolf JF, et al. The relationship of circulating dehydroepiandrosterone, testosterone, and estradiol to stages of the menopausal transition and ethnicity. J Clin Endocrinol Metab 2002;87(8):3760–3767.

    Article  PubMed  CAS  Google Scholar 

  33. Burger HG, Dudley EC, Cui J, Dennerstein L, Hopper JL. A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition. J Clin Endocrinol Metab 2000;85(8):2832–2838.

    Article  PubMed  CAS  Google Scholar 

  34. Hughes CL,Jr., Wall LL, Creasman WT. Reproductive hormone levels in gynecologic oncology patients undergoing surgical castration after spontaneous menopause. Gynecol Oncol 1991;40(1):42–45.

    Article  PubMed  Google Scholar 

  35. Bachmann G, Bancroft J, Braunstein G, et al. Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment. Fertil Steril 2002;77(4):660–665.

    Article  PubMed  Google Scholar 

  36. Cooke BM, Woolley CS. Gonadal hormone modulation of dendrites in the mammalian CNS. J Neurobiol 2005;64(1):34–46.

    Article  PubMed  CAS  Google Scholar 

  37. Patchev VK, Schroeder J, Goetz F, Rohde W, Patchev AV. Neurotropic action of androgens: principles, mechanisms and novel targets. Exp Gerontol 2004;39(11-12):1651–1660.

    Article  PubMed  CAS  Google Scholar 

  38. Baulieu EE. Neurosteroids: a novel function of the brain. Psychoneuroendocrinology 1998;23(8):963–987.

    Article  PubMed  CAS  Google Scholar 

  39. Cameron DR, Braunstein GD. The use of dehydroepiandrosterone therapy in clinical practice. Treat Endocrinol 2005;4(2):95–114.

    Article  Google Scholar 

  40. Greenblatt RB, Barfield WE, Garner JF, Calk GL, Harrod JPJr. Evaluation of an estrogen, androgen, estrogen-androgen combination, and a placebo in the treatment of the menopause. J Clin Endocrinol Metab 1950;10(12):1547–1558.

    Article  PubMed  CAS  Google Scholar 

  41. Sherwin BB, Gelfand MM, Brender W. Androgen enhances sexual motivation in females: a prospective, crossover study of sex steroid administration in the surgical menopause. Psychosom Med 1985;47(4):339–351.

    PubMed  CAS  Google Scholar 

  42. Goldstat R, Briganti E, Tran J, Wolfe R, Davis SR. Transdermal testosterone therapy improves well-being, mood, and sexual function in premenopausal women. Menopause 2003;10(5):390–398.

    Article  PubMed  Google Scholar 

  43. Shifren JL, Braunstein GD, Simon JA, et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 2000;343(10):682–688.

    Article  PubMed  CAS  Google Scholar 

  44. Sherwin BB, Gelfand MM. Differential symptom response to parenteral estrogen and/or androgen administration in the surgical menopause. Am J Obstet Gynecol 1985;151(2):153–160.

    PubMed  CAS  Google Scholar 

  45. Morris NM, Udry JR, Khan-Dawood F, Dawood MY. Marital sex frequency and midcycle female testosterone. Arch Sex Behav 1987;16(1):27–37.

    Article  PubMed  CAS  Google Scholar 

  46. Van Goozen SH, Wiegant VM, Endert E, Helmond FA, Vande Poll NE. Psychoendocrinological assessment of the menstrual cycle: the relationship between hormones, sexuality, and mood. Arch Sex Behav 1997;26(4):359–382.

    Article  PubMed  Google Scholar 

  47. Riley A, Riley E. Controlled studies on women presenting with sexual drive disorder: I. Endocrine status. J Sex Marital Ther 2000;26(3):269–283.

    Article  PubMed  CAS  Google Scholar 

  48. Persky H, Dreisbach L, Miller WR, et al. The relation of plasma androgen levels to sexual behaviors and attitudes of women. Psychosom Med 1982;44(4):305–319.

    PubMed  CAS  Google Scholar 

  49. Floter A, Nathorst-Boos J, Carlstrom K, von Schoultz B. Addition of testosterone to estrogen replacement therapy in oophorectomized women: effects on sexuality and well-being. Climacteric 2002;5(4):357–365.

    Article  PubMed  CAS  Google Scholar 

  50. Davis SR, Davison SL, Donath S, Bell RJ. Circulating androgen levels and self-reported sexual function in women. JAMA 2005;294(1):91–96.

    Article  PubMed  CAS  Google Scholar 

  51. Appelt H, Strauss B. Effects of antiandrogen treatment on the sexuality of women with hyperandrogenism. Psychother Psychosom 1984;42(1-4):177–181.

    PubMed  CAS  Google Scholar 

  52. Buster JE, Kingsberg SA, Aguirre O, et al. Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial. Obstet Gynecol 2005;105(5 Pt 1):944–952.

    Google Scholar 

  53. Braunstein GD, Sundwall DA, Katz M, et al. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial. Arch Intern Med 2005;165(14):1582–1589.

    Article  PubMed  CAS  Google Scholar 

  54. Simon J, Braunstein G, Nachtigall L, et al. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J Clin Endocrinol Metab 2005;90(9)5226–5233.

    Article  PubMed  CAS  Google Scholar 

  55. Lobo RA, Rosen RC, Yang HM, Block B, VanDer Hoop RG. Comparative effects of oral esterified estrogens with and without methyltestosterone on endocrine profiles and dimensions of sexual function in postmenopausal women with hypoactive sexual desire. Fertil Steril 2003;79(6):1341–1352.

    Article  PubMed  Google Scholar 

  56. Davis SR, Tran J. Testosterone influences libido and well being in women. Trends Endocrinol Metab 2001;12(1):33–37.

    Article  PubMed  CAS  Google Scholar 

  57. Notelovitz M. Androgen effects on bone and muscle. Fertil Steril 2002;77(Suppl 4):S34–S41.

    Article  PubMed  Google Scholar 

  58. Marcus R, Leary D, Schneider DL, Shane E, Favus M, Quigley CA. The contribution of testosterone to skeletal development and maintenance: lessons from the androgen insensitivity syndrome. J Clin Endocrinol Metab 2000;85(3):1032–1037.

    Article  PubMed  CAS  Google Scholar 

  59. Kearns AE, Khosla S. Potential anabolic effects of androgens on bone. Mayo Clin Proc 2004;79(4 Suppl):S14–S18.

    PubMed  CAS  Google Scholar 

  60. Speroff L, Rowan J, Symons J, Genant H, Wilborn W. The comparative effect on bone density, endometrium, and lipids of continuous hormones as replacement therapy (CHART study). A randomized controlled trial. JAMA 1996;276(17):1397–1403.

    Article  PubMed  CAS  Google Scholar 

  61. Erdtsieck RJ, Pols HA, van Kuijk C, etal. Course of bone mass during and after hormonal replacement therapy with and without addition of nandrolone decanoate. J Bone Miner Res 1994;9(2):277–283.

    Article  PubMed  CAS  Google Scholar 

  62. Raisz LG, Wiita B, Artis A, et al. Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women. J Clin Endocrinol Metab 1996;81(1):37–43.

    Article  PubMed  CAS  Google Scholar 

  63. Dimitrakakis C, Zhou J, Wang J, et al. A physiologic role for testosterone in limiting estrogenic stimulation of the breast. Menopause 2003;10(4):292–298.

    Article  PubMed  Google Scholar 

  64. Somboonpom W, Davis SR. Testosterone effects on the breast: implications for testosterone therapy for women. Endocr Rev 2004;25(3):374–388.

    Article  CAS  Google Scholar 

  65. Dimitrakakis C, Jones RA, Liu A, Bondy CA. Breast cancer incidence in postmenopausal women using testosterone in addition to usual hormone therapy. Menopause 2004;11(5):531–535.

    Article  PubMed  Google Scholar 

  66. Rosenfield RL, Deplewski D. Role of androgens in the developmental biology of the pilosebaceous unit. Am J Med 1995;98(1A):80S–88S.

    Article  PubMed  CAS  Google Scholar 

  67. Deplewski D, Rosenfield RL. Role of hormones in pilosebaceous unit development. Endocr Rev 2000 2000;21(4):363–392.

    Article  CAS  Google Scholar 

  68. Kaufman KD. Androgens and alopecia. Mol Cell Endocrinol 2002;198(1-2):89–95.

    Article  PubMed  CAS  Google Scholar 

  69. Eckardstein Av, Wu FCW. Testosterone and atherosclerosis. Growth Hormone IGF Res 2003;13(Suppl 1):S72–S84.

    Article  CAS  Google Scholar 

  70. Barrett-Connor E, Goodman-Gruen D. Prospective study of endogenous sex hormones and fatal cardiovascular disease in postmenopausal women. BMJ 1995;31 1(7014):1193–1196.

    Google Scholar 

  71. Olsen NJ, Kovacs WJ. Gonadal steroids and immunity. Endocr Rev 1996;17(4):369–384.

    Article  PubMed  CAS  Google Scholar 

  72. Rosenfield RL. Pilosebaceous physiology in relation to hirsutism and acne. Clin Endocrinol Metab 1986;15(2):341–362.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA

    T. Keta Hodgson

  2. Department of Medicine, Cedars-Sinai Medical Center, Department of Medicine, The David Geffen School of Medicine at University of California, Los Angeles, CA

    Glenn D. Braunstein

Authors
  1. T. Keta Hodgson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Glenn D. Braunstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Center for Androgen Related Disorders, Cedars-Sinai Medical Center; and Department of Obstetrics and Gynecology, and Department of Medicine, The David Geffen School of Medicine at UCLA, Los Angeles, CA

    Ricardo Azziz MD, MPH, MBA

  2. Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA

    John E. Nestler MD

  3. Department of Endocrine Gynaecology and Reproductive Medicine, Lille University Hospital, Lille, France

    Didier Dewailly MD

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Hodgson, T.K., Braunstein, G.D. (2006). Physiological Effects of Androgens in Women. In: Azziz, R., Nestler, J.E., Dewailly, D. (eds) Androgen Excess Disorders in Women. Contemporary Endocrinology. Humana Press. https://doi.org/10.1007/978-1-59745-179-6_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-179-6_4

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-663-4

  • Online ISBN: 978-1-59745-179-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation